Free Trial

Adaptimmune Therapeutics (ADAP) Institutional Ownership

Adaptimmune Therapeutics logo
$0.59 -0.02 (-3.12%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$0.59 0.00 (0.00%)
As of 01/31/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Adaptimmune Therapeutics (NASDAQ:ADAP)

Current
Institutional Ownership
Percentage
31.37%
Number of
Institutional Buyers
(last 12 months)
13
Total
Institutional Inflows
(last 12 months)
$4.12M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$5.88M
Get ADAP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Adaptimmune Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ADAP Institutional Buying and Selling by Quarter

Adaptimmune Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/31/2025Baillie Gifford & Co.11,819,095$6.37M0.0%-29.5%4.619%
11/20/2024Virtu Financial LLC101,008$96K0.0%+27.5%0.039%
11/15/2024Jane Street Group LLC174,157$166K0.0%+130.4%0.068%
11/15/2024Matrix Capital Management Company LP37,681,515$35.81M1.7%-3.3%14.734%
11/14/2024PFM Health Sciences LP10,000,787$9.51M0.5%-4.9%3.911%
11/13/2024FMR LLC1,740,900$1.66M0.0%+3.0%0.681%
11/5/2024Baillie Gifford & Co.16,775,860$15.94M0.0%+10.7%6.560%
11/5/2024GSA Capital Partners LLP99,662$95K0.0%N/A0.039%
10/29/2024Fullcircle Wealth LLC35,000$33K0.0%N/A0.014%
10/16/2024 Vontobel Holding Ltd.43,000$41K0.0%+230.8%0.017%
8/15/2024Long Focus Capital Management LLC12,346,417$12.04M0.5%+15.6%5.002%
8/14/2024Marshall Wace LLP144,880$141K0.0%-43.0%0.059%
8/9/2024Renaissance Technologies LLC1,786,341$1.74M0.0%+28.3%0.724%
7/25/2024Baillie Gifford & Co.15,149,203$14.77M0.0%-4.6%6.138%
5/15/2024Baker BROS. Advisors LP10,787,022$17.04M0.2%-1.7%4.370%
5/14/2024Boulder Hill Capital Management LP90,800$143K0.1%N/A0.037%
5/3/2024GSA Capital Partners LLP370,179$585K0.0%-27.2%0.150%
5/1/2024Baillie Gifford & Co.15,871,875$25.08M0.0%-0.3%6.431%
4/19/2024 JTC Employer Solutions Trustee Ltd26,156$41K0.0%N/A0.003%
4/15/2024 Key Client Fiduciary Advisors LLC268,655$424K0.2%-20.2%0.027%
4/15/2024 Columbia Advisory Partners LLC15,585$25K0.0%N/A0.002%
3/5/2024Twin Focus Capital Partners LLC55,526$44K0.0%N/A0.006%
1/26/2024Baillie Gifford & Co.15,912,140$12.62M0.0%-7.2%1.600%
1/9/2024 Key Client Fiduciary Advisors LLC336,620$267K0.2%+6.4%0.034%
1/8/2024 Harbor Capital Advisors Inc.147,732$117K0.0%+9.9%0.015%
11/13/2023Baillie Gifford & Co.17,147,409$13.38M0.0%-0.2%1.725%
10/27/2023 Marquette Asset Management LLC99,349$77K0.0%N/A0.010%
10/27/2023Acuitas Investments LLC479,764$374K0.2%N/A0.048%
10/20/2023 Harbor Capital Advisors Inc.134,415$105K0.0%+19.5%0.014%
9/21/2023Barclays PLC50,061$46K0.0%N/A0.005%
9/7/2023MPM Asset Management LLC6,287,101$5.82M2.9%N/A0.632%
8/15/2023Black Maple Capital Management LP69,839$65K0.0%N/A0.007%
8/14/2023X Square Capital LLC26,771$25K0.0%N/A0.003%
8/14/2023CSS LLC IL90,702$84K0.0%N/A0.009%
8/11/2023Artal Group S.A.1,133,775$1.05M0.0%N/A0.114%
8/7/2023Acadian Asset Management LLC358,010$329K0.0%+15.1%0.036%
8/3/2023Oppenheimer & Co. Inc.68,171$63K0.0%N/A0.007%
7/28/2023Baillie Gifford & Co.17,176,135$15.89M0.0%+0.4%1.728%
7/11/2023 Harbor Capital Advisors Inc.112,516$104K0.0%N/A0.073%
5/17/2023Long Focus Capital Management LLC5,435,439$5.93M0.3%+2.9%3.514%
Is this Elon’s true agenda? (Ad)

All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them

5/12/2023Long Focus Capital Management LLC2,772,791$3.02M0.3%-47.5%1.793%
5/10/2023Simplify Asset Management Inc.150,000$164K0.0%N/A0.097%
5/3/2023Baillie Gifford & Co.17,112,002$18.65M0.0%-0.3%11.064%
5/1/2023Virtu Financial LLC88,234$96K0.0%+193.1%0.057%
4/25/2023 Key Client Fiduciary Advisors LLC321,155$350K0.2%+8.2%0.208%
2/15/2023Endurant Capital Management LP1,733,236$2.53M1.0%-3.1%1.058%
2/14/2023Susquehanna International Group LLP28,126$41K0.0%N/A0.017%
2/9/2023HBK Sorce Advisory LLC70,000$65K0.0%+100.0%0.043%
1/17/2023 Key Client Fiduciary Advisors LLC296,740$433K0.3%-31.9%0.181%
1/11/2023 Vigilare Wealth Management28,800$42K0.0%-21.7%0.018%
11/15/2022PFM Health Sciences LP9,320,584$10.02M0.4%+2.3%5.689%
11/15/2022Long Focus Capital Management LLC4,789,490$5.15M0.5%+2.4%2.923%
11/15/2022Endurant Capital Management LP1,788,517$1.92M0.6%-1.9%1.092%
11/14/2022HBK Sorce Advisory LLC35,000$32K0.0%N/A0.021%
11/10/2022ExodusPoint Capital Management LP370,288$398K0.0%+23.4%0.227%
11/7/2022Virtu Financial LLC40,503$44K0.0%+133.7%0.025%
11/3/2022Barclays PLC340,068$366K0.0%+34.6%0.208%
10/27/2022Baillie Gifford & Co.14,664,936$15.76M0.0%-4.3%8.977%
10/12/2022 Key Client Fiduciary Advisors LLC435,985$469K0.4%+4.8%0.267%
8/12/2022Rafferty Asset Management LLC217,123$369K0.0%-59.5%0.134%
8/11/2022Alps Advisors Inc.96,110$163K0.0%N/A0.059%
8/10/2022 Hunter Associates Investment Management LLC28,500$49K0.0%+42.5%0.018%
8/8/2022Baillie Gifford & Co.15,321,346$26.05M0.0%-0.4%9.457%
7/11/2022 Vigilare Wealth Management41,800$71K0.1%N/A0.026%
5/17/2022Endurant Capital Management LP2,160,890$4.45M1.2%+140.7%1.335%
5/16/2022Eversept Partners LP237,086$488K0.0%-32.0%0.151%
5/11/2022GSA Capital Partners LLP69,612$143K0.0%-17.3%0.044%
5/5/2022Baillie Gifford & Co.15,380,538$31.68M0.0%+11.8%9.805%
5/5/2022Levy Wealth Management Group LLC17,590$36K0.0%N/A0.011%
4/29/2022Daiwa Securities Group Inc.35,516$73K0.0%+44.9%0.023%
4/26/2022 Hunter Associates Investment Management LLC20,000$41K0.0%+81.8%0.013%
4/21/2022 Inspire Investing LLC31,928$66K0.0%+107.4%0.020%
4/21/2022Inspire Advisors LLC45,105$93K0.0%+193.0%0.029%
4/18/2022 Key Client Fiduciary Advisors LLC420,447$866K0.7%+58.0%0.268%
2/14/2022Long Focus Capital Management LLC2,162,313$8.11M1.1%N/A1.384%
2/14/2022Point72 Asset Management L.P.565,208$2.12M0.0%+640.8%0.362%
2/14/2022DAFNA Capital Management LLC136,266$511K0.1%N/A0.087%
2/14/2022Eversept Partners LP348,716$1.31M0.1%-21.6%0.223%
2/14/2022GSA Capital Partners LLP84,129$315K0.0%-82.6%0.054%
2/11/2022Syncona Portfolio Ltd1,377,294$5.17M4.9%N/A0.882%
2/10/2022Rafferty Asset Management LLC606,763$2.28M0.0%-18.1%0.388%
2/8/2022Bank of America Corp DE538,111$2.02M0.0%-26.5%0.344%
2/8/2022ProShare Advisors LLC19,315$72K0.0%-34.0%0.012%
2/7/2022Mitsubishi UFJ Kokusai Asset Management Co. Ltd.69,140$281K0.0%+13.6%0.044%
2/3/2022Daiwa Securities Group Inc.24,515$92K0.0%+59.4%0.016%
2/3/2022 Inspire Investing LLC15,393$58K0.0%N/A0.010%
1/27/2022 Hunter Associates Investment Management LLC11,000$41K0.0%N/A0.007%
1/20/2022Baillie Gifford & Co.13,756,352$51.59M0.0%+7.3%8.807%
12/1/2021Balyasny Asset Management LLC259,413$1.34M0.0%N/A0.166%
11/18/2021Personal CFO Solutions LLC36,388$188K0.0%+19.7%0.023%
Is this Elon’s true agenda? (Ad)

All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them

11/16/2021Schonfeld Strategic Advisors LLC349,683$1.81M0.0%-1.7%0.224%
11/16/2021ACT Capital L.L.C.90,000$465K0.2%N/A0.058%
11/16/2021Squarepoint Ops LLC31,881$165K0.0%+127.8%0.020%
11/16/2021Toroso Investments LLC10,554$55K0.0%N/A0.007%
11/16/2021Millennium Management LLC1,584,849$8.19M0.0%+70.3%1.015%
11/15/2021Point72 Asset Management L.P.76,300$394K0.0%-96.3%0.049%
11/15/2021Cubist Systematic Strategies LLC57,953$300K0.0%+485.4%0.037%
11/15/2021Man Group plc148,305$767K0.0%+44.2%0.095%
11/15/2021Tudor Investment Corp Et Al16,004$83K0.0%N/A0.010%
11/15/2021Rock Springs Capital Management LP2,189,788$11.32M0.2%+41.7%1.403%
(Data available from 1/1/2016 forward)

ADAP Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ADAP shares?

During the previous two years, 33 institutional investors and hedge funds held shares of Adaptimmune Therapeutics. The most heavily invested institutionals were Matrix Capital Management Company LP ($35.81M), Baker BROS. Advisors LP ($17.04M), Long Focus Capital Management LLC ($12.04M), PFM Health Sciences LP ($9.51M), Baillie Gifford & Co. ($6.37M), MPM Asset Management LLC ($5.82M), and Endurant Capital Management LP ($2.53M).Learn more on ADAP's institutional investors.

What percentage of Adaptimmune Therapeutics stock is owned by institutional investors?

31.37% of Adaptimmune Therapeutics stock is owned by institutional investors. Learn more on ADAP's institutional investor holdings.

Which institutional investors have been buying Adaptimmune Therapeutics stock?

Of the 28 institutional investors that purchased Adaptimmune Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: MPM Asset Management LLC ($6.29M), Long Focus Capital Management LLC ($1.81M), Baillie Gifford & Co. ($1.69M), Artal Group S.A. ($1.13M), Acuitas Investments LLC ($479.76K), Renaissance Technologies LLC ($394.57K), and Simplify Asset Management Inc. ($150K).

How much institutional buying is happening at Adaptimmune Therapeutics?

Institutional investors have bought a total of 13,239,155 shares in the last 24 months. This purchase volume represents approximately $12.48M in transactions.

Which Adaptimmune Therapeutics major shareholders have been selling company stock?

Of the 9 institutional investors that sold Adaptimmune Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Baillie Gifford & Co. ($7.04M), Long Focus Capital Management LLC ($2.51M), Matrix Capital Management Company LP ($1.29M), PFM Health Sciences LP ($519.44K), Baker BROS. Advisors LP ($182.26K), GSA Capital Partners LLP ($138.63K), and Marshall Wace LLP ($109.13K).

How much institutional selling is happening at Adaptimmune Therapeutics?

Institutional investors have sold a total of 11,917,864 shares in the last 24 months. This volume of shares sold represents approximately $9.76M in transactions.



This page (NASDAQ:ADAP) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners